Boosting lung cancer screening for patients seen in the emergency department
Official title: Increasing Lung Cancer Screening Uptake Among Emergency Department Patients
Run by University of Rochester · NCT07287085 · Data updated 2026-11-12
This project will test whether giving eligible emergency department patients a facilitated referral plus text reminders helps more people get lung cancer screening.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 80 Years |
| Sex | All |
| Enrollment | 349 (estimated) |
| Sponsor | University of Rochester Academic / other |
| Locations | 1 site (Rochester, New York) |
| Status | Recruiting |
| Started | March 18, 2026 |
| Main results expected | March 2028 |
| Study ends | November 2028 |
| Registry record updated | May 4, 2026 |
| Trial ID | NCT07287085 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 50–80 with a ≥20 pack-year smoking history who currently smoke or quit within the past 15 years, who speak English, are current patients in the University of Rochester Medical Center emergency department, and who have a text-capable mobile phone are ideal candidates.
✕Probably not a fit
People who cannot use text messaging, who do not speak English, who are too medically unstable to consent, or who already have completed appropriate lung cancer screening are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will identify 300 emergency department patients at high risk for lung cancer based on age and smoking history and confirm they can receive text messages. Eligible participants will be randomized to either a basic referral (verbal plus written information) or a facilitated referral where staff submit a requisition to the screening program and the patient receives a series of text-message reminders. Participants will be followed for 120 days to compare lung cancer screening completion between the two groups. The design builds on prior feasibility work in the ED and targets a pragmatic, low-cost approach to increase screening uptake.
Why it matters
Potential benefit: If successful, the approach could increase the number of high-risk patients who complete lung cancer screening, enabling earlier detection and treatment.
How similar studies have gone: Investigators' pilot work showed this approach was feasible in the ED, and text-message reminders have improved screening uptake in other settings, though ED-based facilitated referral for lung cancer screening is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 50 - 80 * ≥ 20 pack-year smoking history * current smoker or quit within 15 years * English speaking * Current patient in URMC involved Emergency Department Exclusion Criteria: * Non-English * Inability to provide consent (e.g. high clinical acuity, cognitive deficit) * Lack of text-capable mobile phone and/or inability to use text function * Not being a patient in URMC involved Emergency Department There are no restrictions for gender, racial and ethnic origins.
Where it's running
-
University of Rochester
Rochester, New York, United States Recruiting
Study contacts
- Study coordinator: Peter MacDowell
- Email: peter_macdowell@urmc.rochester.edu
- Phone: 585-274-1509
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Risk-based lung cancer screening in COPD patients using ML and clinical models
This study tests whether a PLCOm2012 risk model plus a machine learning model can spot COPD patients at high risk for lung cancer to see if they benefit from low-dose CT screening.
-
AI-Personalized Discharge Education After Lung Cancer Surgery
This study tests whether an AI-generated, personalized discharge guide helps patients recover better after lung cancer surgery compared with standard discharge education.
-
Next Generation Delivery System (NGDS) for SBRT in thorax and upper abdomen
A study tests a new machine to deliver SBRT more quickly and comfortably for adults with thoracic or upper abdominal cancers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.